OVID

Ovid Therapeutics
$2.35
+$0.02 (+0.86%)Jul 27, 2026
4.0NeutralMoatMint rating

MoatMint rates Ovid Therapeutics (OVID) 4.0 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.7 out of 10.

Key metrics

The numbers that frame OVID today
Market cap
$438.60M
P/E (TTM)
-18.1
EV / FCF
-8.5
Gross margin
100%
EV / Sales
49.9
ROIC
-26.2%
Div yield
0%
Debt / equity
0.1
52wk Low
$0.48
52wk High
$3.11

OVID stock rating

How OVID scores on quality, value, growth, momentum and financial health
4.0out of 10
Neutral overallFair business, expensive priceTop 60% of ~5,000 US stocks
QualityPoor0.7/10
GrowthFair2.9/10
MomentumGreat9.5/10
ValueFair2.2/10
Financial HealthGreat8.6/10

Growth

Revenue and earnings trend for OVID
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about OVID
Is Ovid Therapeutics a good buy?
Hold. Ovid Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Ovid Therapeutics is selling at a very high price.
What is the market capitalization of OVID?
Ovid Therapeutics's market capitalization is $438.60M.
What is the P/E ratio for OVID stock?
Ovid Therapeutics's current P/E ratio is -18.1.
What is the 52-week high for OVID stock?
The 52-week high for Ovid Therapeutics is $3.11. The current close of $2.35 is 24.3% below that high.
What is the 52-week low for OVID stock?
The 52-week low for Ovid Therapeutics is $0.48. The current close of $2.35 is 394.7% above that low.
Does OVID stock pay dividends?
Ovid Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for OVID?
Ovid Therapeutics's Debt / Equity ratio is 0.07.